Toggle Nav
My Cart
English
Español
Menu
Account
  • Log in / Register
    • Language
    English
    Español

    Wyeth Pharmaceuticals: Spurring Scientific Creativity with Metrics

    Pisano, Gary P. ; Rennella, Mark ; Huckman, Robert S.

    • Reference: HBS-607008-E

    • Year: 2006

    • Number of pages: 25

    • Geographic Setting: United States

    • Publication Date: Feb 7, 2007

    • Fecha de edición: Apr 6, 2010

    • Source: HBSP (USA)

    • Type of Document: Case

    • Industry Setting: Pharmaceuticals

    Grouped product items
    Format Language Reference Use Qty Price
    pdf English HBS-607008-E
    As low as €8.20

    You already have a subscription
    To order please contact the person in charge of academic purchases in your university.
    You'll be able to order once your profile has been validated.

    Description

    Describes the reorganization of the drug discovery organization at Wyeth Pharmaceuticals and focuses on the decisions to: (1) centralize decision-making within drug discovery and (2) institute numerical metrics--jointly affecting all R&D scientists--for the progression of compounds through the Wyeth pipeline. Highlights issues concerning the degree to which scientific activity can be evaluated via numerical metrics, the extent to which R&D can be structured as a process, and the degree to which decision-making should be centralized in commercial R&D activities. May be used in combination with HBS case 605-074 (GlaxoSmithKline: Reorganizing Drug Discovery (A)) to contrast the use of centralized and decentralized models of decision-making in pharmaceutical R&D.

    Related Documents

    Keywords

    Competitive environment Competitive Strategy Creativity Metrics Organizational design Organizational structure Performance measurement Productivity R&D Reorganization Restructuring